Insider · CIK 0001815042
Vignesh Rajah
Files at YMAB (Y-mAbs Therapeutics, Inc.). First filing Mar 7, 2024, latest Mar 7, 2024.
In brief
Vignesh Rajah files SEC Form 4 as officer at YMAB (Y-mAbs Therapeutics, Inc.). Since Mar 7, 2024, Vignesh Rajah has reported 0 open-market buys worth $0 and 1 open-market sell worth $28k, the latest filed on Mar 7, 2024.
A track record needs three past buys with six months of prices behind them; Vignesh Rajah has 0, so none is measured yet.
The newest scored trade: sold $28k of YMAB on Mar 5, 2024, filed Mar 7, 2024, scored 35 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Y-mAbs Therapeutics, Inc. | $28k 1,711 shares | -5% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 7, 2025 | YMAB Y-mAbs Therapeutics, Inc. | 4,946 0.01% of outstanding | $26k | Mar 7, 2025 | none |
| Mar 6, 2024 | YMAB Y-mAbs Therapeutics, Inc. | 1,711 0.00% of outstanding | $28k | Mar 5, 2024 | none |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 5, 2024 | YMAB Y-mAbs Therapeutics, Inc. | SOpen-market sale Common Stock | -1,711 | $16.53 | $28k | 33,889 | Mar 7, 2024 |
| Jan 18, 2024 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Common Stock | +17,800 | $0.00 | $0 | 35,600 | Jan 22, 2024 |
| Jan 18, 2024 | YMAB Y-mAbs Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +35,700 | $0.00 | $0 | 35,700 | Jan 22, 2024 |
Questions about Vignesh Rajah
Answered from the filings on this page, as of the latest one.
Is Vignesh Rajah buying or selling?
Not in the last 12 months. Vignesh Rajah's latest open-market trade on SEC Form 4 was sold $28k of YMAB on Mar 5, 2024.
How did Vignesh Rajah's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Vignesh Rajah has 0.
Where does Vignesh Rajah file Form 4?
Vignesh Rajah has filed Form 4 at YMAB (Y-mAbs Therapeutics, Inc.) as SVP & CHIEF MEDICAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.